Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 16 2021

Full Issue

Pfizer Targets November To Apply For Vaccine Authorization For Kids Under 5

Pfizer CEO Albert Bourla says clinical trial data on how well his company's covid vaccine works in 6-month to 5-year-old children could be released as early as the end of October. For children aged 5 to 11, emergency authorization could come sooner.

The Hill: Pfizer Plans To Seek Vaccine Authorization In November For Kids Under 5

Pfizer and BioNTech plan to file for Food and Drug Administration (FDA) emergency authorization in November for their COVID-19 vaccine for children younger than 5, Pfizer Chief Financial Officer Frank D'Amelio said this week. Pfizer has previously said the company expects to file in early October for emergency use authorization in children ages 5 to 11. (Weixel, 9/15)

CNBC: Pfizer's Covid Vaccine Data For Kids Under Age 5 May Come In Late October, CEO Says

Pfizer expects to release clinical trial data on how well its Covid-19 vaccine works in 6-month to 5-year-old children as early as the end of October, CEO Albert Bourla said Tuesday. Covid vaccine data for kids between ages 5 and 11 will come much sooner, he said, potentially ready to be submitted to the Food and Drug Administration by the end of this month. (Lovelace Jr., 9/14)

Children ages 5-11 may be able to get the shot before Halloween —

ABC7 San Francisco: California Counties Prepare To Vaccinate Kids 5-11 Years Old Ahead Of Pfizer's Expected Emergency Authorization 

Pfizer is planning to submit data to the Food and Drug Administration by the end of this month with hopes for a green light to start vaccinating kids 5 to 11 years old before Halloween. Health officers across the Bay Area are starting to prepare how distribution will work once the vaccine is authorized for emergency use. ... Susan Rojas works with San Francisco's COVID-19 taskforce. Her staff is already preparing to expand the Mission's 24th Street pop-up site to be able to vaccinate up to 500 children per day once Pfizer's vaccine is authorized. "We have a lot of families coming in trying to figure out if they can put their names on a waitlist," she said. (Sierra, 9/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF